Statins have been linked to far fewer side effects than commonly believed, according to evidence discussed by a leading cardiovascular specialist, with a large review finding little support for many of the concerns that have made the cholesterol-lowering medicines controversial.
The findings were examined during Saga’s health podcast, where Professor Bryan Williams, chief scientific and medical officer of the British Heart Foundation, discussed the longstanding debate over the drugs with presenter Dr Mark Porter. Statins are prescribed to reduce cholesterol and help prevent cardiovascular disease, including heart attacks and strokes.
Professor Williams said statins had attracted an unusual level of public suspicion compared with other medicines used to protect the heart and circulation.
“It’s probably the most controversial drug,” Professor Williams said.
He said he had not understood why statins had remained so prominently “in the firing line”, given that people regularly take other treatments for blood pressure and cardiovascular protection. The debate has nevertheless persisted, with patients and the public often associating statins with a wide range of possible harms.
What the evidence examined
The review, led by Oxford Population Health and part-funded by the British Heart Foundation, analysed data from 150,000 people across 23 clinical trials. Most of the trials compared a statin with a dummy treatment, or placebo, allowing researchers to assess whether reported symptoms were more common among people taking the medicine.
Researchers considered 66 additional potential side effects. Only four were found to have an association with statins, and those effects occurred in only a very small proportion of patients. The findings did not support a broad link between the medicines and many of the symptoms frequently discussed in public debate.
| Evidence examined | Finding |
|---|---|
| Participants | 150,000 |
| Clinical trials | 23 |
| Potential additional side effects assessed | 66 |
| Effects associated with statins | 4, affecting a very small proportion of patients |
Which effects were associated?
The four associations identified were abnormal liver transaminases, other abnormalities in liver-function tests, changes in the composition of urine and oedema. Oedema is swelling caused by a build-up of fluid. The review did not find evidence that the full range of widely suspected problems was caused by statins.
- Liver-related changes: abnormal transaminases and other liver-function test abnormalities.
- Urinary changes: alterations in urine composition.
- Fluid retention: oedema, or swelling linked to fluid accumulation.
Concerns previously associated with statins have included memory loss, depression, liver disease, sleep disturbance, weight gain, erectile problems and muscle pain. The review’s findings suggest that most of these suspected effects were not attributable to the drugs in the clinical trial data examined.
Muscle pain and public confidence
Muscle symptoms have been central to concerns about statin treatment. Earlier research by the same team examined reports of muscle pain and found that 14 out of 15 reports were not caused by statins. This distinction is important because symptoms can occur for many reasons, particularly among people who may already have other health conditions or be taking several medicines.
The evidence does not remove the need for patients and clinicians to discuss symptoms or possible adverse effects. It does, however, challenge the idea that statins routinely cause a wide range of serious problems. For people being offered treatment to lower cardiovascular risk, the balance between expected benefit and possible harm remains a central part of informed decision-making.
Professor Williams described statins as medicines that can save lives and said independent research was important in assessing their effects. He also linked the prevention of cardiovascular disease to improvements in population health over recent decades, describing it as one of medicine’s major achievements.
“Research like this plays such an important role because research is independent and statins can save lives,” Professor Williams said.
The findings provide evidence for a more measured discussion of statins, particularly at a time when fears about side effects may affect whether people start or continue treatment. They also underline the importance of relying on clinical-trial evidence rather than assuming that every symptom reported while taking a medicine has been caused by it.
